v3.25.2
Segment Reporting
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Reporting

Note 15 – Segment Reporting

 

The Company has determined that it currently operates in a single segment, precision medicine in cancer treatment, currently located in a single geographic location, the United States. The accounting policies of the segment are the same as those described in the summary of significant accounting policies. Since the Company operates in a single segment, the measure of segment total assets and loss from operations is the same as that reported on the accompanying balance sheets as total assets, and the accompanying statement of operations as loss from operations, respective.

 

The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The Company’s CODM reviews and evaluates the total consolidated net loss for purposes of assessing performance, making operating decisions, allocating resources, and planning and forecasting for future periods. In addition to the significant expense categories included within the total net loss presented on the Company’s Statements of Operations, the following table sets forth significant segment expenses:

 

   2024   2023 
   December 31, 
   2024   2023 
Patient revenue, net  $72,050   $- 
Cost of revenues   305,248    - 
Gross profit (loss)   (233,198)   - 
           
Operating expenses          
Employee expense   1,759,061    1,348,382 
Professional fees   2,820,541    872,366 
Occupancy   162,956    124,249 
Insurance   311,997    325,585 
Loss on disposition or impairment   -    3,433,884 
Other   335,514    271,042 
Total operating expenses   5,390,069    6,375,508 
           
Operating loss   (5,623,267)   (6,375,508)
           
Interest income   

3,470

    

27,156

 
Other income (expense)   

-

    

(2,040

)
Interest expense   (677,981)   (124,966)
Total other income (expenses)   

(674,511

)   (99,850)
           
Income (loss) from continuing operations, net of income taxes  $(6,297,778)  $(6,475,358)